

Cardiac Monitoring and Diagnostic Devices Market
Scope: Industry Analysis, Market Size, Growth,
Trends Till 2031
Request Sample Report
The global cardiac monitoring and diagnostic devices market is projected to reach a value of $12.63 billion by 2027, with a compound annual growth rate of 4.6%. Factors such as the increasing prevalence of cardiovascular diseases and advancements in technology are driving market growth. The market is highly competitive and fragmented, with key players including Medtronic, Abbott Laboratories, and GE Healthcare. Key trends in the market include the adoption of wearable cardiac monitoring devices and the development of remote monitoring solutions.
Request Sample Report
◍ Abbott
◍ Applied Cardiac Systems
◍ Bi-biomed
◍ Bio Telemetry
◍ BORSAM
◍ EDAN
◍ Fukuda Denshi
◍ GE Healthcare
◍ Hill-Rom
◍ Innomed
◍ iRhythm
◍ Medicalgorithmics
◍ Medicomp
◍ Medtronic
◍ MidMark
◍ Mindray Medical
◍ NIHON KOHDEN
◍ Philips Healthcare
The Cardiac Monitoring and Diagnostic Devices Market is highly competitive with key players such as Abbott, Medtronic, GE Healthcare, Philips Healthcare, and Welch Allyn offering a range of products and services. These companies leverage innovative technology and strategic partnerships to drive growth in the market.
- Abbott: $10.7 billion
- Medtronic: $30.6 billion
- GE Healthcare: $19.1 billion
Hospital
Clinical
Others
Request Sample Report
Electrocardiograph
ECG Recorder
Heart Rate Meter
ECG Telemetering
Others
Request Sample Report
$ X Billion USD